Establishing the role of honest broker: bridging the gap between protecting personal health data and clinical research efficiency

Author:

Choi Hyo Joung1,Lee Min Joung1,Choi Chang-Min123,Lee JaeHo145,Shin Soo-Yong14,Lyu Yungman1,Park Yu Rang46,Yoo Soyoung7

Affiliation:

1. Office of Clinical Research Information, Asan Institute of Life Sciences, Asan Medical Center, Seoul, Korea

2. Department of Pulmonology and Critical Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

3. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

4. Department of Biomedical Informatics, Asan Medical Center, Seoul, Korea

5. Department of Emergency Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

6. Clinical Research Center, Asan Institute of Life Sciences, Asan Medical Center, Seoul, Korea

7. Human Research Protection Center, Asan Institute of Life Sciences, Asan Medical Center, Seoul, Korea

Abstract

Background.The objective of this study is to propose the four conditions for the roles of honest brokers through a review of literature published by ten institutions that are successfully utilizing honest brokers. Furthermore, the study aims to examine whether the Asan Medical Center’s (AMC) honest brokers satisfy the four conditions, and examine the need to enhance their roles.Methods.We analyzed the roles, tasks, and types of honest brokers at 10 organizations by reviewing the literature. We also established a Task Force (TF) in our institution for setting the roles and processes of the honest broker system and the honest brokers. The findings of the literature search were compared with the existing systems at AMC—which introduced the honest broker system for the first time in Korea.Results.Only one organization employed an honest broker for validating anonymized clinical data and monitoring the anonymity verifications of the honest broker system. Six organizations complied with HIPAA privacy regulations, while four organizations did not disclose compliance. By comparing functions with those of the AMC, the following four main characteristics of honest brokers were determined: (1) de-identification of clinical data; (2) independence; (3) checking that the data are used only for purposes approved by the IRB; and (4) provision of de-identified data to researchers. These roles were then compared with those of honest brokers at the AMC.Discussion.First, guidelines that regulate the definitions, purposes, roles, and requirements for honest brokers are needed, since there are no currently existing regulations. Second, Korean clinical research institutions and national regulatory departments need to reach a consensus on a Korean version of Limited Data Sets (LDS), since there are no lists that describe the use of personal identification information. Lastly, satisfaction surveys on honest brokers by researchers are necessary to improve the quality of honest brokers.

Funder

Korean Health Technology R&D Project

Asan Institute for Life Sciences

Publisher

PeerJ

Subject

General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Reference34 articles.

1. Evaluating re-identification risks with respect to the HIPAA privacy rule;Benitez;Journal of the American Medical Informatics Association,2010

2. An ‘Honest Broker’ mechanism to maintain privacy for patient care and academic medical research;Boyd;International Journal of Medical Informatics,2007

3. The University of Michigan Honest Broker: a web-based service for clinical and translational research and practice;Boyd;Journal of the American Medical Informatics Association,2009

4. CBTTC informatics platform,2015

5. Conforming to HIPAA regulations and compilation of research data;Clause;American Journal of Health-System Pharmacy,2004

Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3